.AstraZeneca executives say they are "not troubled" that the failure of tozorakimab in a period 2 se...
.Accept to today's Chutes & Ladders, our roundup of substantial management hirings, firings as we...
.After revealing programs to attack the U.S. public markets lower than a month back, Zenas Biopharma...
.Psyence Biomedical is paying $500,000 in portions to get fellow psilocybin-based biotech Clairvoyan...
.Five months after endorsing Electrical Rehabs' Pivya as the very first new therapy for simple urina...
.Eli Lilly has risen in to an AI-enabled medication finding package, partnering with RNA expert Here...
.Lykos CEO as well as creator Amy Emerson is leaving, along with principal operating officer Michael...
.Novartis levels a brand new outpost in its cooperation with Voyager Rehabs, spending $15 million to...
.On the heels of an FDA rejection for its chief rival Novo Nordisk, Eli Lilly is picking up speed in...
.Only a couple of months after dosing the first patient in a stage 2 test for newly detected gliobla...